Osteoarthritis Therapy Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Market Report I 2024-02-02 I 199 Pages I The Insight Partners
The osteoarthritis therapy market size is projected to grow from US$ 17.36 billion in 2022 to US$ 30.68 billion by 2030; the market is estimated to record a CAGR of 7.4% during 2022-2030. The rising prevalence of osteoarthritis and innovative therapy options reducing dependency on medications are the key factors propelling the osteoarthritis therapy market development. However, product recall hamper the osteoarthritis therapy market growth. Furthermore, more effective treatment options to fuel osteoarthritis therapy acts as a lucrative market trend during the forecast period.
Growth Drivers:
Rising Prevalence of Osteoarthritis Drives Osteoarthritis Therapy Market Growth
Globally, OA affects more than 500 million people, accounting for 7% of the world's population, according to the CDC report. It represents a major cause of long-term disability. Osteoarthritis is more prevalent among athletes and people who sustain joint injury or trauma. Moreover, it is more prevalent among women, accounting for 60% of global osteoarthritis cases.
According to the World Health Organization (WHO) report, osteoarthritis is more prevalent among the older population. Also, OA can affect anyone, but the condition is most commonly observed in adults aged 40 years and above. Also, the WHO report further reveals that about 73% of the population is older than 55 years and living with OA, among which 60% are female. According to the Centers for Disease Control and Prevention (CDC) report, over 32.5 million adults in the US are affected by OA. Thus, with the rising prevalence of OA and, new therapy options, such as biological therapy, are gaining attention worldwide. Platelet-rich plasma (PRP) therapy is one example that has emerged as a promising OA treatment. PRP enhances tissue recovery by catalyzing the body's natural healing and tissue repair processes.
Report Segmentation and Scope:
The osteoarthritis therapy market is segmented into therapy type, disease indication, and end user. Based on therapy type, the market is segmented into Transcutaneous Electrical Nerve Stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy and stromal vascular fraction, prolotherapy, and others. The market is segmented by disease indication into knee osteoarthritis, spine osteoarthritis, foot & ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. In terms of end-users, the market is segmented into hospitals & clinics, specialty clinics, ambulatory surgical centers (ASCs), homecare, and others.
?
Therapy Type-Based Insights
By therapy type, the osteoarthritis therapy market is segmented as transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma and stromal vascular fraction, prolotherapy, and others. The physical therapy segment held the largest market share of the osteoarthritis therapy market by therapy type segment in 2022. The others segment is anticipated to grow at the fastest CAGR of 7.5% during the forecast period. The physical therapy segment held the largest market share of the osteoarthritis therapy market by therapy type segment in 2022. The other segment is anticipated to grow at the fastest CAGR of 7.5% during the forecast period. Physical therapies, such as yoga, help improve physical function in patients affected by knee osteoarthritis. The clinical study reveals that the patients suffering from knee osteoarthritis receiving physical therapy (PT) have gained more quality-adjusted life-years than those receiving glucocorticoid injections. Additionally, physical therapy is clinically more effective than glucocorticoid injection; moreover, it is perceived as a more cost-effective option.
The other segment is estimated to register the highest CAGR for the osteoarthritis therapy market. Another therapy is rehabilitation therapy for osteoarthritis. The rehabilitation program is designed to reduce pain and increase functionality quickly. The rehabilitation's main goal is to relieve knee OA symptoms and slow its progression. The future perspective and rehabilitation include nonpharmacological management of OA followed by exercise, which effectively improves the quality of life, joint function, muscle power, strength, and functional performance. Therefore, modifications in rehabilitation programs will ultimately reduce the patients' osteoarthritis pain, bolstering the osteoarthritis therapy market growth during the forecast period.
Disease Based Insights
The knee osteoarthritis segment held the largest market share of the osteoarthritis therapy market by disease indication segment in 2022, and the same segment is anticipated to grow at the fastest CAGR of 7.7% during the forecast period. According to the National Academy of Science report, knee osteoarthritis (KO) accounts for more than 80% of the total disease burden, affecting nearly 19% of American adults aged 45 years and above annually. Launches of innovative products by manufacturers can help reduce the burden of knee osteoarthritis. In September 2021, Contura International Ltd announced a new product launch, "Arthrosamid," an alternative to current therapy that fulfills an unmet clinical need for a safe, effective, long-acting, and minimally invasive treatment for alleviating pain associated with knee OA. Therefore, the rising prevalence of knee OA and innovative product launches to minimize osteoarthritis pain drive the osteoarthritis therapy market growth.
End User-Based Insights
The homecare segment held the largest market share of the osteoarthritis therapy market by end-user segment in 2022. Additionally, the hospitals & clinics segment is estimated to register the highest CAGR of 7.5% during the forecast period. The first and foremost remedy to overcome arthritis is reducing excess body weight. Additionally, hot and cold therapies can bring back flexibility in stiff joints, which can help reduce joint pain. The use of electric blankets or moist heating pads proves helpful in reducing pain. However, cold treatments such as packs of ice or bags of frozen vegetables can be applied to the affected joints, giving relief. Availability of such treatment options proves to be a successful remedy for managing osteoarthritis at home, which drives the osteoarthritis therapy market growth for the homecare segment.
Regional Analysis:
Based on geography, the global osteoarthritis therapy market is segmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America held the largest global osteoarthritis therapy market share. Asia Pacific is expected to register the highest CAGR during 2022-2030. In the North American market, the US accounts for the largest market share of the osteoarthritis therapy market. According to the statistics revealed in the Centers for Disease Control and Prevention (CDC) report, osteoarthritis (OA) is the most common form of arthritis, affecting 32.5 million adults in the US. Additionally, the Osteoarthritis (OA) Action Alliance report reveals that the overall economic burden associated with OA in the US is estimated at US$ 136.8 billion annually. Further, the American Roentgen Ray Society ARRS report reveals that the lifetime risk of OA is 50%, and it is estimated that by 2040, ~78 million (26%) adults in the country will have OA.
Further, new product approvals by the manufacturers aiming for non-pharmacology therapy for OA pain influence the osteoarthritis therapy market growth. In June 2021, CyMedica Orthopedics announced receiving FDA approval for the "Intellihab System," a noninvasive modality for knee osteoarthritis pain. The new product launch is a therapeutic and digital-based ecosystem that is designed to treat OA pain with a debilitating osteoarthritis disease. Therefore, new non-pharmacology therapy intended to reduce dependency on therapeutics in OA treatment would fuel the growth of the osteoarthritis therapy market during the forecast period.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Osteoarthritis Therapy Market Landscape
4.1 PEST Analysis
4.2 Pipeline Analysis
4.2.1 Clinical Trial Pipeline Analysis
5. Osteoarthritis Therapy Market - Key Market Dynamics
5.1 Osteoarthritis Therapy Market - Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Osteoarthritis
5.2.2 Innovative Therapy Options Reducing Dependency on Medications
5.3 Market Restraints
5.3.1 Product Recall
5.4 Market Opportunities
5.4.1 Availability of Regenerative Medicine
5.5 Future Trends
5.5.1 More Effective Treatment Options
5.6 Impact of Drivers and Restraints:
6. Osteoarthritis Therapy Market - Global Market Analysis
6.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2022-2030
6.1.1 Overview
6.1.2 Osteoarthritis Therapy Market Revenue (US$ Million), 2022-2030
7. Osteoarthritis Therapy Market Analysis - by Therapy Type
7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
7.2.1 Overview
7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
7.3.1 Overview
7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
7.4.1 Overview
7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
7.5.1 Overview
7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
7.6.1 Overview
7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8. Osteoarthritis Therapy Market Analysis - by Disease Indication
8.1 Overview
8.2 Knee Osteoarthritis
8.2.1 Overview
8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
8.3.1 Overview
8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
8.4.1 Overview
8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
8.5.1 Overview
8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
8.6.1 Overview
8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9. Osteoarthritis Therapy Market Analysis - by End User
9.1 Overview
9.2 Hospitals and Clinics
9.2.1 Overview
9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
9.3.1 Overview
9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
9.5.1 Overview
9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10. Osteoarthritis Therapy Market - Geographical Analysis
10.1 Overview North America
10.1.1 North America Osteoarthritis Therapy Market Overview
10.1.2 North America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.1 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
10.1.2.2 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
10.1.2.3 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
10.1.3 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
10.1.3.1 United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.3.1.1 Overview
10.1.3.1.2 United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.3.1.3 United States: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.3.1.4 United States: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.3.1.5 United States: Osteoarthritis Therapy Market Breakdown, by End User
10.1.3.2 Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.3.2.1 Overview
10.1.3.2.2 Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.3.2.3 Canada: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.3.2.4 Canada: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.3.2.5 Canada: Osteoarthritis Therapy Market Breakdown, by End User
10.1.3.3 Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.3.3.1 Overview
10.1.3.3.2 Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.3.3.3 Mexico: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.3.3.4 Mexico: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.3.3.5 Mexico: Osteoarthritis Therapy Market Breakdown, by End User
10.2 Europe
10.2.1 Europe Osteoarthritis Therapy Market Overview
10.2.2 Europe: Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Million)
10.2.2.1 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
10.2.2.2 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
10.2.2.3 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
10.2.3 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
10.2.3.1 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.2.3.1.1 Overview
10.2.3.1.2 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.2.3.1.3 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.2.3.1.4 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.2.3.1.5 United Kingdom: Osteoarthritis Therapy Market Breakdown, by End User
10.2.3.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.2.3.2.1 Overview
10.2.3.2.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.2.3.2.3 Germany: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.2.3.2.4 Germany: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.2.3.2.5 Germany: Osteoarthritis Therapy Market Breakdown, by End User
10.2.3.3 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.2.3.3.1 Overview
10.2.3.3.2 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.2.3.3.3 France: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.2.3.3.4 France: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.2.3.3.5 France: Osteoarthritis Therapy Market Breakdown, by End User
10.2.3.4 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.2.3.4.1 Overview
10.2.3.4.2 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.2.3.4.3 Italy: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.2.3.4.4 Italy: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.2.3.4.5 Italy: Osteoarthritis Therapy Market Breakdown, by End User
10.2.3.5 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.2.3.5.1 Overview
10.2.3.5.2 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.2.3.5.3 Spain: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.2.3.5.4 Spain: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.2.3.5.5 Spain: Osteoarthritis Therapy Market Breakdown, by End User
10.2.3.6 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.2.3.6.1 Overview
10.2.3.6.2 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.2.3.6.3 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.2.3.6.4 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.2.3.6.5 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by End User
10.3 Asia Pacific
10.3.1 Asia Pacific Osteoarthritis Therapy Market Overview
10.3.2 Asia Pacific: Osteoarthritis Therapy Market
10.3.2.1 Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
10.3.2.2 Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
10.3.2.3 Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
10.3.3 Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
10.3.3.1 China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.3.3.1.1 Overview
10.3.3.1.2 China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.3.3.1.3 China: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.3.3.1.4 China: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.3.3.1.5 China: Osteoarthritis Therapy Market Breakdown, by End User
10.3.3.2 Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.3.3.2.1 Overview
10.3.3.2.2 Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.3.3.2.3 Japan: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.3.3.2.4 Japan: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.3.3.2.5 Japan: Osteoarthritis Therapy Market Breakdown, by End User
10.3.3.3 India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.3.3.3.1 Overview
10.3.3.3.2 India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.3.3.3.3 India: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.3.3.3.4 India: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.3.3.3.5 India: Osteoarthritis Therapy Market Breakdown, by End User
10.3.3.4 Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.3.3.4.1 Overview
10.3.3.4.2 Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.3.3.4.3 Australia: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.3.3.4.4 Australia: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.3.3.4.5 Australia: Osteoarthritis Therapy Market Breakdown, by End User
10.3.3.5 South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.3.3.5.1 Overview
10.3.3.5.2 South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.3.3.5.3 South Korea: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.3.3.5.4 South Korea: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.3.3.5.5 South Korea: Osteoarthritis Therapy Market Breakdown, by End User
10.3.3.6 Rest of APAC: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.3.3.6.1 Overview
10.3.3.6.2 Rest of APAC: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.3.3.6.3 Rest of APAC: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.3.3.6.4 Rest of APAC: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.3.3.6.5 Rest of APAC: Osteoarthritis Therapy Market Breakdown, by End User
10.4 Middle East and Africa
10.4.1 Middle East and Africa Osteoarthritis Therapy Market Overview
10.4.2 Middle East and Africa: Osteoarthritis Therapy Market
10.4.2.1 Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
10.4.2.2 Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
10.4.2.3 Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
10.4.3 Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
10.4.3.1 South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.4.3.1.1 Overview
10.4.3.1.2 South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.4.3.1.3 South Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.4.3.1.4 South Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.4.3.1.5 South Africa: Osteoarthritis Therapy Market Breakdown, by End User
10.4.3.2 Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.4.3.2.1 Overview
10.4.3.2.2 Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.4.3.2.3 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.4.3.2.4 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.4.3.2.5 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by End User
10.4.3.3 United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.4.3.3.1 Overview
10.4.3.3.2 United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.4.3.3.3 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.4.3.3.4 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.4.3.3.5 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by End User
10.4.3.4 Rest of Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.4.3.4.1 Overview
10.4.3.4.2 Rest of Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.4.3.4.3 Rest of Middle East and Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.4.3.4.4 Rest of Middle East and Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.4.3.4.5 Rest of Middle East and Africa: Osteoarthritis Therapy Market Breakdown, by End User
10.5 South and Central America
10.5.1 South and Central America Osteoarthritis Therapy Market Overview
10.5.2 South and Central America: Osteoarthritis Therapy Market
10.5.2.1 South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
10.5.2.2 South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
10.5.2.3 South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
10.5.3 South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
10.5.3.1 Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.5.3.1.1 Overview
10.5.3.1.2 Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.5.3.1.3 Brazil: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.5.3.1.4 Brazil: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.5.3.1.5 Brazil: Osteoarthritis Therapy Market Breakdown, by End User
10.5.3.2 Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.5.3.2.1 Overview
10.5.3.2.2 Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.5.3.2.3 Argentina: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.5.3.2.4 Argentina: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.5.3.2.5 Argentina: Osteoarthritis Therapy Market Breakdown, by End User
10.5.3.3 Rest of South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.5.3.3.1 Overview
10.5.3.3.2 Rest of South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.5.3.3.3 Rest of South and Central America: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.5.3.3.4 Rest of South and Central America: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.5.3.3.5 Rest of South and Central America: Osteoarthritis Therapy Market Breakdown, by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Global Osteoarthritis Therapy Market
11.3 Organic Developments
11.3.1 Overview
11.1 Inorganic Developments
11.1.1 Overview
12. Company Profiles
12.1 Vision Quest Industries Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Dr PRP USA LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Estar Technologies Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Zimmer Biomet Holdings Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 DePuy Synthes Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Bioventus Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Omron Healthcare Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Exactech Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Medi GmbH & Co KG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Zealmax Innovations Pvt Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
LIST OF TABLES
Table 1. Osteoarthritis Therapy Market Segmentation
Table 2. Ongoing Clinical Trial of Osteoarthritis
Table 3. North America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 4. North America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 5. North America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 7. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 8. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 10. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 11. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 13. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 14. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 16. Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 17. Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 18. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 19. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 20. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 21. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 22. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 23. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 24. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 25. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 26. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 27. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 28. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 29. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 30. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 31. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 32. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 33. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 34. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 35. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 36. Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 37. Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 38. Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 39. China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 40. China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 41. China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 42. Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 43. Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 44. Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 45. India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 46. India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 47. India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 48. Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 49. Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 50. Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 51. South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 52. South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 53. South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 54. Rest of APAC: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 55. Rest of APAC: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 56. Rest of APAC: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 57. Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 58. Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 59. Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 60. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 61. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 62. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 63. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 64. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 65. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 66. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 67. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 68. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 69. Rest of Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 70. Rest of Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 71. Rest of Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 72. South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 73. South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 74. South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 75. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 76. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 77. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 78. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 79. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 80. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 81. Rest of South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 82. Rest of South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 83. Rest of South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 84. Organic Developments Done by Companies
Table 85. Inorganic Developments Done by Companies
LIST OF FIGURES
Figure 1. Osteoarthritis Therapy Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2022-2030
Figure 5. Osteoarthritis Therapy Market, By Geography Forecast Analysis, 2022 & 2030
Figure 6. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)
Figure 7. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)
Figure 14. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)
Figure 21. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. North America: Osteoarthritis Therapy Market by Key Countries - Revenue (2022) US$ Million
Figure 27. North America Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. North America: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 29. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. Europe: Osteoarthritis Therapy Market - Revenue by Key Countries Revenue 2022 (US$ Million)
Figure 33. Europe Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. Europe: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 35. United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 38. Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 39. Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 40. Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 41. Asia Pacific: Osteoarthritis Therapy Market - Revenue by Key Countries 2022 (US$ Million)
Figure 42. Asia Pacific: Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Asia Pacific: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 44. China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 45. Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 46. India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 47. Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 48. South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 49. Rest of APAC: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 50. Middle East and Africa: Osteoarthritis Therapy Market - Revenue by Key Countries 2022 (US$ Million)
Figure 51. Middle East and Africa: Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 52. Middle East and Africa: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 53. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 54. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 55. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 56. Rest of Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 57. South and Central America: Osteoarthritis Therapy Market - Revenue by Key Countries 2022 (US$ Million)
Figure 58. South and Central America: Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. South and Central America: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 60. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 61. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 62. Rest of South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 63. Growth Strategies in the Global Osteoarthritis Therapy Market
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.